|
|
||||||||
From the Center for Functional Imaging (Drs. Eberling, Reed, and Jagust), Lawrence Berkeley Laboratory, University of California, Berkeley; and the Department of Neurology (Drs. Eberling, Reed, and Jagust), University of California (UC) at Davis and UC Davis Alzheimers Disease Center (Drs. Eberling, Reed, Coleman, and Jagust), Davis, CA.
Address correspondence and reprint requests to Dr. Eberling, Center for Functional Imaging, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Mail Stop 55-121, Berkeley, CA 94720; e-mail: eberling{at}cfi.lbl.gov
PET was used to evaluate the effect of estrogen use on regional cerebral glucose metabolism in postmenopausal women. Women receiving estrogen replacement therapy (ERT+), women not receiving estrogen (ERT-), and women with AD were studied. The ERT- group showed metabolic ratios that were intermediate to the ERT+ and AD groups, although they did not show any signs of cognitive impairment. These findings show an effect of estrogen depletion on brain metabolic activity.
This article has been cited by other articles:
![]() |
S. M. Resnick, M. A. Espeland, S. A. Jaramillo, C. Hirsch, M. L. Stefanick, A. M. Murray, J. Ockene, C. Davatzikos, and For the Women's Health Initiative Memory Study Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study Neurology, January 13, 2009; 72(2): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |